Jay Michael Dintaman
MD
Colonel, Army
Education
University of Delaware, Newark, DE BS 06/1996 BiochemistryUniformed Services University of Health Sciences, Bethesda, MD MD 05/2003
National Capital Consortium, Bethesda, MD Resident 06/2006 Pediatrics
National Capital Consortium, Bethesda, MD Fellow 06/2011 Neonatal-Perinatal Medicine
Biography
Colonel Jay M. Dintaman is a board certified Neonatal-Perinatal specialist currently serving as the Commandant, USUHS School of Medicine, Graduate Education Office, and Enlisted to Medical Doctor Degree Program. Previous positions include serving as Chief of Army Medical Readiness, Office of the Surgeon General and Chief of the Integrated Neonatology Service at the Walter Reed National Military Medical Center, Bethesda MD. COL Dintaman has additional operational experience with assignments as Flight Surgeon for the 2-2 Aviation Battalion in Seoul, Korea and as the Command Surgeon for the Warrior Transition Brigade-National Capital Region in Bethesda, MD. His clinical research interests include measuring quality care in newborn medicine within the military medical community and studying the Warrior Care and Transition Program to further define its population and document program outcomes.Representative Bibliography
a. Nestander M, Dintaman J, Susi A, Gorman G, Hisle-Gorman E. Immunization Completion in Infants Born at Low Birth Weight. J Pediatric Infect Dis Soc. 2017 Sep 23;PubMed PMID: 29036471.
b. Chen Q, Dintaman J, Lees A, Sen G, Schwartz D, Shirtliff ME, Park S, Lee JC, Mond JJ, Snapper CM. Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine. Infect Immun. 2013 Jul;81(7):2554-61. PubMed PMID: 23649092; PubMed Central PMCID: PMC3697627.
c. Dintaman J, Watson C, Fox CJ, Hoover N, Roberts S, Gillespie DL. Case of adolescent with Paget-Schroetter syndrome and underlying thrombophilia due to an elevated lipoprotein (A). Pediatr Blood Cancer. 2007 Dec;49(7):1036-8. PubMed PMID: 16496286.
d. Dintaman JM, Silverman JA. Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res. 1999 Oct;16(10):1550-6. PubMed PMID: 10554096.